Nobel Biocare signs syndicated loan facility

(PresseBox) ( Zürich, Switzerland, )
Nobel Biocare announced today the closing of a EUR 330 million committed syndicated banking facility with 6 international banks and a maturity of 3 years. The facility is designed to optimize current funding and serves also as a backup line to increase the company's financial flexibility going forward.

Dirk Kirsten, CFO, said: "In the current financial markets environment the successful closing of such a transaction is an important achievement. This is testimony of our leading market position with intact long-term perspectives, our strong balance sheet and a strong operating cash flow in 2008".
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to